Carregant...
Chimeric Antigen Receptor T-Cell Therapy for the Community Oncologist
The field of cancer immunotherapy has rapidly progressed in the past decade as several therapeutic modalities have entered into the clinic. One such immunotherapy that has shown promise in the treatment of cancer is the use of chimeric antigen receptor (CAR)-modified T lymphocytes. CARs are engineer...
Guardat en:
| Publicat a: | Oncologist |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AlphaMed Press
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4861363/ https://ncbi.nlm.nih.gov/pubmed/27009942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0421 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|